Sunshine Biopharma (SBFM) Retained Earnings (2016 - 2025)
Historic Retained Earnings for Sunshine Biopharma (SBFM) over the last 14 years, with Q3 2025 value amounting to -$72.9 million.
- Sunshine Biopharma's Retained Earnings fell 896.01% to -$72.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$72.9 million, marking a year-over-year decrease of 896.01%. This contributed to the annual value of -$69.0 million for FY2024, which is 803.39% down from last year.
- Latest data reveals that Sunshine Biopharma reported Retained Earnings of -$72.9 million as of Q3 2025, which was down 896.01% from -$72.0 million recorded in Q2 2025.
- In the past 5 years, Sunshine Biopharma's Retained Earnings ranged from a high of -$26.4 million in Q1 2021 and a low of -$72.9 million during Q3 2025
- Over the past 5 years, Sunshine Biopharma's median Retained Earnings value was -$62.0 million (recorded in 2023), while the average stood at -$53.5 million.
- Per our database at Business Quant, Sunshine Biopharma's Retained Earnings crashed by 8189.95% in 2022 and then plummeted by 593.45% in 2024.
- Sunshine Biopharma's Retained Earnings (Quarter) stood at -$32.7 million in 2021, then plummeted by 81.9% to -$59.4 million in 2022, then dropped by 7.59% to -$63.9 million in 2023, then decreased by 8.03% to -$69.0 million in 2024, then fell by 5.55% to -$72.9 million in 2025.
- Its Retained Earnings was -$72.9 million in Q3 2025, compared to -$72.0 million in Q2 2025 and -$70.2 million in Q1 2025.